Cargando…
Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma
Combined BRAF and MEK inhibition is an effective treatment for BRAF-mutant cutaneous melanoma. However, most patients progress on this treatment due to drug resistance. Here, we applied the Sleeping Beauty transposon system to understand how melanoma evades MAPK inhibition. We found that the specifi...
Autores principales: | Zhu, Eliot Y., Schillo, Jacob L., Murray, Sarina D., Riordan, Jesse D., Dupuy, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582486/ https://www.ncbi.nlm.nih.gov/pubmed/37860756 http://dx.doi.org/10.1016/j.isci.2023.107805 |
Ejemplares similares
-
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas
por: Zhu, Eliot Y., et al.
Publicado: (2022) -
Sequencing methods and datasets to improve functional interpretation of sleeping beauty mutagenesis screens
por: Riordan, Jesse D, et al.
Publicado: (2014) -
RNA sequencing of Sleeping Beauty transposon-induced tumors detects transposon-RNA fusions in forward genetic cancer screens
por: Temiz, Nuri A., et al.
Publicado: (2016) -
Sleeping Beauty Mouse Models of Cancer: Microenvironmental Influences on Cancer Genetics
por: Guimaraes-Young, Amy, et al.
Publicado: (2019) -
A simplified transposon mutagenesis method to perform phenotypic forward genetic screens in cultured cells
por: Feddersen, Charlotte R., et al.
Publicado: (2019)